TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow November 8, 1996
TCL Archive President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel June 1, 2001
TCL Archive Cancer Groups Fear Clinical Trials Coverage Will Not Be Implemented Across Exchanges July 3, 2013
